Terms: = Leukemia AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217 AND Treatment
27 results:
1. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
2. Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.
Bonnet S; Carillo S; Legrand B; Burroni B; Lavabre-Bertrand T; Requirand G; Robert N; Fornero L; Al Mansoori A; Moreaux J; Cartron G; Gabellier L; Herbaux C
Eur J Haematol; 2024 Mar; 112(3):475-478. PubMed ID: 37918825
[TBL] [Abstract] [Full Text] [Related]
3. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract] [Full Text] [Related]
4. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
Romzova M; Smitalova D; Hynst J; Tom N; Loja T; Herudkova Z; Jurcek T; Stejskal L; Zackova D; Mayer J; Racil Z; Culen M
Br J Haematol; 2021 Aug; 194(3):604-612. PubMed ID: 34212373
[TBL] [Abstract] [Full Text] [Related]
5. Mutant setbp1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
Carratt SA; Braun TP; Coblentz C; Schonrock Z; Callahan R; Curtiss BM; Maloney L; Foley AC; Maxson JE
Leukemia; 2021 Dec; 35(12):3594-3599. PubMed ID: 34002029
[TBL] [Abstract] [Full Text] [Related]
6. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Jian J; Qiao Y; Li Y; Guo Y; Ma H; Liu B
Clin Transl Oncol; 2021 Sep; 23(9):1731-1742. PubMed ID: 33861431
[TBL] [Abstract] [Full Text] [Related]
7. CSF3R T618I, setbp1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Y; Chen Y; Li X
Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
[TBL] [Abstract] [Full Text] [Related]
8. Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.
Wang H; Guo Y; Dong Z; Li T; Xie X; Wan D; Jiang Z; Yu J; Guo R
Sci Rep; 2020 Oct; 10(1):18622. PubMed ID: 33122737
[TBL] [Abstract] [Full Text] [Related]
9. Atypical Chronic Myeloid leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract] [Full Text] [Related]
10. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
[TBL] [Abstract] [Full Text] [Related]
11. [Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil leukemia].
Guo YJ; Wang Y; Wang LH; Zuo YB; Niu ZY; Lin FR; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):82-87. PubMed ID: 32027257
[TBL] [Abstract] [Full Text] [Related]
12. Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
Martín I; Navarro B; Serrano A; Villamón E; Calabuig M; Solano C; Chaves FJ; Yagüe N; Orts M; Amat P; Fuentes A; Seda E; García F; Hernández-Boluda JC; Tormo M
Ann Hematol; 2020 Mar; 99(3):527-537. PubMed ID: 31989250
[TBL] [Abstract] [Full Text] [Related]
13. Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing.
Li Y; Lv X; Ge X; Yuan D; Ding M; Zhen C; Zhao W; Liu X; Wang X; Xu H; Li Y; Wang X
Mol Med Rep; 2019 May; 19(5):4147-4158. PubMed ID: 30942411
[TBL] [Abstract] [Full Text] [Related]
14. Chronic Neutrophilic leukemia: Current and Future Perspectives.
Venugopal S; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):129-134. PubMed ID: 30581159
[TBL] [Abstract] [Full Text] [Related]
15. Current and evolving understanding of atypical chronic myeloid leukemia.
Schwartz LC; Mascarenhas J
Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
[TBL] [Abstract] [Full Text] [Related]
16. Bone marrow - mesenchymal stem cells impact on the U937 cells in the presence of staphylococcal enterotoxin B (seb).
Ejtehadifar M; Halabian R; Ghazavi A; Khansarinejad B; Mosayebi G; Imani Fooladi AA
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):849-858. PubMed ID: 29655181
[TBL] [Abstract] [Full Text] [Related]
17. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
18. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
Tefferi A; Lasho TL; Patnaik MM; Saeed L; Mudireddy M; Idossa D; Finke C; Ketterling RP; Pardanani A; Gangat N
Am J Hematol; 2017 Dec; 92(12):1311-1317. PubMed ID: 28875545
[TBL] [Abstract] [Full Text] [Related]
19. Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy.
Kim T; Tyndel MS; Zhang Z; Ahn J; Choi S; Szardenings M; Lipton JH; Kim HJ; Kim Dong Hwan D
Leuk Res; 2017 Aug; 59():142-148. PubMed ID: 28667884
[TBL] [Abstract] [Full Text] [Related]
20. Clonal evolution in therapy-related neoplasms.
Fabiani E; Falconi G; Fianchi L; Criscuolo M; Ottone T; Cicconi L; Hohaus S; Sica S; Postorino M; Neri A; Lionetti M; Leone G; Lo-Coco F; Voso MT
Oncotarget; 2017 Feb; 8(7):12031-12040. PubMed ID: 28076841
[TBL] [Abstract] [Full Text] [Related]
[Next]
